CN103864761A - 一种含吡啶的哌嗪类衍生物及其制备方法和用途 - Google Patents
一种含吡啶的哌嗪类衍生物及其制备方法和用途 Download PDFInfo
- Publication number
- CN103864761A CN103864761A CN201410088582.3A CN201410088582A CN103864761A CN 103864761 A CN103864761 A CN 103864761A CN 201410088582 A CN201410088582 A CN 201410088582A CN 103864761 A CN103864761 A CN 103864761A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- acceptable salt
- pharmacy acceptable
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410088582.3A CN103864761B (zh) | 2014-03-12 | 2014-03-12 | 一种含吡啶的哌嗪类衍生物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410088582.3A CN103864761B (zh) | 2014-03-12 | 2014-03-12 | 一种含吡啶的哌嗪类衍生物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103864761A true CN103864761A (zh) | 2014-06-18 |
CN103864761B CN103864761B (zh) | 2016-01-20 |
Family
ID=50903831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410088582.3A Active CN103864761B (zh) | 2014-03-12 | 2014-03-12 | 一种含吡啶的哌嗪类衍生物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103864761B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1098098A (zh) * | 1991-05-02 | 1995-02-01 | 约翰韦恩兄弟有限公司 | 哌嗪衍生物 |
WO2000005206A1 (en) * | 1998-07-21 | 2000-02-03 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
EP1724267A1 (en) * | 2004-02-26 | 2006-11-22 | ASKA Pharmaceutical Co., Ltd. | Pyrimidine derivative |
US20070036715A1 (en) * | 2005-08-11 | 2007-02-15 | Park Sang H | Tc-labeled arylpiperazine derivatives for imaging serotonin receptor |
WO2011150183A1 (en) * | 2010-05-28 | 2011-12-01 | Ge Healthcare Limited | Radiolabeled compounds and methods thereof |
-
2014
- 2014-03-12 CN CN201410088582.3A patent/CN103864761B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1098098A (zh) * | 1991-05-02 | 1995-02-01 | 约翰韦恩兄弟有限公司 | 哌嗪衍生物 |
WO2000005206A1 (en) * | 1998-07-21 | 2000-02-03 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
EP1724267A1 (en) * | 2004-02-26 | 2006-11-22 | ASKA Pharmaceutical Co., Ltd. | Pyrimidine derivative |
US20070036715A1 (en) * | 2005-08-11 | 2007-02-15 | Park Sang H | Tc-labeled arylpiperazine derivatives for imaging serotonin receptor |
WO2011150183A1 (en) * | 2010-05-28 | 2011-12-01 | Ge Healthcare Limited | Radiolabeled compounds and methods thereof |
CN102918031A (zh) * | 2010-05-28 | 2013-02-06 | 通用电气健康护理有限公司 | 放射标记的化合物及其方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103864761B (zh) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101402641B (zh) | 含噻吩并吡啶的肟类衍生物、其制备方法和用途 | |
CA2295446C (en) | Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same | |
JP5290190B2 (ja) | イミダゾール−5−カルボン酸誘導体の塩、製造方法及びその医薬組成物 | |
CN101450939B (zh) | 新型苯并咪唑类化合物 | |
CN106478605A (zh) | 嘧啶类化合物、其制备方法和医药用途 | |
CN102241690A (zh) | 一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途 | |
CN103058972B (zh) | 一类含环己烷结构的苯基c-葡萄糖苷衍生物、其制备方法和用途 | |
CN101974015A (zh) | 酯类化合物、其制备方法和用途 | |
CN101974016A (zh) | 酰胺类化合物及其制备方法和用途 | |
CN105026399B (zh) | 作为钾离子通道抑制剂的吡咯并三嗪类化合物 | |
CN103864761B (zh) | 一种含吡啶的哌嗪类衍生物及其制备方法和用途 | |
CN103012314B (zh) | 磺胺类化合物及其制备方法和应用 | |
CN105646354B (zh) | 一种咪唑类化合物 | |
CN104292211A (zh) | 地氯雷他定类一氧化氮供体及其制备方法和用途 | |
CN103420890A (zh) | 3-吡咯甲酸衍生物及其制备方法和用途 | |
CN103626722B (zh) | 一氧化氮供体型降血糖化合物、其制备方法和用途 | |
CN102786458B (zh) | 吡咯甲酰胺衍生物、其制备方法和用途 | |
CN101863902B (zh) | 2-取代苯基-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)乙酸(取代烷基醇)酯的制备方法和用途 | |
CN101863900B (zh) | 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途 | |
CN103304556B (zh) | 含有苯并吡喃的希夫碱类化合物、其制备方法和用途 | |
CN102796093B (zh) | 含硫代吗啉的吡咯衍生物、其制备方法和用途 | |
CN102796040A (zh) | 1,4-二取代哌嗪衍生物、其制备方法和用途 | |
CN102351878B (zh) | 异恶唑衍生物、其制备方法和用途 | |
CN103965162A (zh) | 磺酰胺类化合物及其制备方法和用途 | |
CN104860919A (zh) | 含哌啶的苯并咪唑衍生物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Applicant after: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Applicant before: Tianjin Institute of Pharmaceutical Research |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH TO: TIANJIN PHARMACEUTICAL INSTITUTE CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220401 Address after: 300301 No. 29, Huixin Road, Binhai Science Park, Binhai high tech Zone, Tianjin Binhai New Area, Tianjin Patentee after: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH PHARMACEUTICAL RESPONSIBLE CO.,LTD. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |
|
TR01 | Transfer of patent right |